Direxion NVDA Defined Income Boost ETF

27.88

+0.90173.34%

Post-market: 27.87-0.0134-0.05%16:10 EDT

Volume:1K

Turnover:34.96K

Market Cap:2.51M

PE:- -

High:28.22

Open:28.21

Low:27.86

Close:26.98

52wk High:28.62

52wk Low:24.54

Shares:90.00K

Float Shares:90.00K

Volume Ratio:2.13

T/O Rate:1.39%

Dividend:0.45

Dividend Rate:1.62%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/NVIB/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVIB\",,,,,undefined,":{"symbol":"NVIB","market":"US","secType":"STK","nameCN":"Direxion NVDA Defined Income Boost ETF","latestPrice":27.8834,"timestamp":1788379200000,"preClose":26.9817,"halted":0,"volume":1252,"hourTrading":{"tag":"盘后","latestPrice":27.87,"preClose":27.8834,"latestTime":"16:10 EDT","volume":6,"amount":167.3004,"timestamp":1788379804455,"change":-0.0134,"changeRate":-0.000481,"amplitude":0},"delay":0,"changeRate":0.033418946915872674,"floatShares":90001,"shares":90001,"eps":0,"marketStatus":"Closed","change":0.9017,"latestTime":"09-02 16:00:00 EDT","open":28.209,"high":28.219,"low":27.86,"amount":34955,"amplitude":0.013305,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788422400000},"marketStatusCode":5,"adr":0,"listingDate":1785297600000,"exchange":"CBOE","adjPreClose":26.9817,"nav":27.01,"aum":2430909.13,"dividendRate":0.016206,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":27.87,"preClose":27.8834,"latestTime":"16:10 EDT","volume":6,"amount":167.3004,"timestamp":1788379804455,"change":-0.0134,"changeRate":-0.000481,"amplitude":0},"volumeRatio":2.130701},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVIB\",,,,,undefined,":{"symbol":"NVIB","floatShares":90001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.130701,"shares":90001,"dividePrice":0.45187,"high":28.219,"amplitude":0.013305,"preClose":26.9817,"low":27.86,"week52Low":24.54,"pbRate":"--","week52High":28.621,"institutionHeld":0,"latestPrice":27.8834,"eps":0,"divideRate":0.016206,"volume":1252,"delay":0,"ttmEps":0,"open":28.209,"prevYearClose":25,"prevWeekClose":27.0104,"prevMonthClose":27.4504,"prevQuarterClose":25,"fiveDayClose":26.097,"twentyDayClose":27.7429},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVIB\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"NVIB","amount":0.21733,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-28","defaultRemindTime":1787923800000,"name":"Direxion NVDA Defined Income Boost ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-31","payableDate":"2026-08-28","currency":"USD","dateTimestamp":1787889600000,"payDate":"2026-08-31"},{"date":"2026-08-14","symbol":"NVIB","amount":0.23454,"announcedDate":"2026-08-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-14","defaultRemindTime":1786714200000,"name":"Direxion NVDA Defined Income Boost ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-17","payableDate":"2026-08-14","currency":"USD","dateTimestamp":1786680000000,"payDate":"2026-08-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVIB\",market:\"US\",,,undefined,":[{"executeDate":"2026-08-14","recordDate":"2026-08-14","paymentDate":"2026-08-17","value":0.23454,"currency":"USD"},{"executeDate":"2026-08-28","recordDate":"2026-08-28","paymentDate":"2026-08-31","value":0.21733,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVIB\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653633037","title":"CSPC Advances HPV mRNA Vaccine SYS6026 to Phase II Trial in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2653633037","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653633037?lang=en_us&edition=fundamental","pubTime":"2026-07-22 21:08","pubTimestamp":1784725684,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group ( ($HK:1093) ) has provided an update. CSPC Pharmaceutical Group has officially launched a Phase II clinical trial in Chi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cspc-advances-hpv-mrna-vaccine-sys6026-to-phase-ii-trial-in-china?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cspc-advances-hpv-mrna-vaccine-sys6026-to-phase-ii-trial-in-china?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","IDNA","HYLG","NVIB","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653768188","title":"NeuroSense Moves PrimeC Toward Health Canada Drug Submission for ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2653768188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653768188?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:56","pubTimestamp":1784725011,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd. ( ($NRSN) ) just unveiled an update. NeuroSense Therapeutics, a late-stage clinical biotech developer of neurodegenera...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurosense-moves-primec-toward-health-canada-drug-submission-for-als?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurosense-moves-primec-toward-health-canada-drug-submission-for-als?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653720383","title":"Imunon announces new preliminary data from IMNN-001 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2653720383","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653720383?lang=en_us&edition=fundamental","pubTime":"2026-07-21 21:25","pubTimestamp":1784640328,"startTime":"0","endTime":"0","summary":"Imunon (IMNN) announced new preliminary data from its ongoing Phase 2 minimal residual disease, or MRD, translational clinical trial of IMNN-001, c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/imunon-announces-new-preliminary-data-from-imnn-001-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/imunon-announces-new-preliminary-data-from-imnn-001-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","IMNN","MEDX","BK4139","HYLG","IDNA","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653784051","title":"Biotech IPO gains crush AI listings with standout 55% return","url":"https://stock-news.laohu8.com/highlight/detail?id=2653784051","media":"Anthony Hughes / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653784051?lang=en_us&edition=fundamental","pubTime":"2026-07-21 12:57","pubTimestamp":1784609865,"startTime":"0","endTime":"0","summary":"The biotechnology sector is stealing the US IPO market thunder from artificial intelligence-related listings, delivering standout returns as bankers line up a steady stream of summer debuts.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/us-stocks/biotech-ipo-gains-crush-ai-listings-standout-55-return?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/us-stocks/biotech-ipo-gains-crush-ai-listings-standout-55-return?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["VTHR","BK4588","IPOS","QTOC","QQQJ","XBIX","AIPO","PEVC","REDS","BK4585","AGIX","LRCY","NVIB","IJT","CHAT","TMFX","XBI","BKIV","KI","BK4127","FRHC","KCE","IPO","BK4581","ARTY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":8,"totalSize":144,"code":"91000000","status":"200"}]}}